4RYP
Crystal Structure of T. Brucei Farnesyl Diphosphate Synthase
4RYP の概要
| エントリーDOI | 10.2210/pdb4ryp/pdb |
| 分子名称 | Farnesyl pyrophosphate synthase (2 entities in total) |
| 機能のキーワード | transferase |
| 由来する生物種 | Trypanosoma brucei |
| タンパク質・核酸の鎖数 | 2 |
| 化学式量合計 | 88951.48 |
| 構造登録者 | |
| 主引用文献 | Liu, Y.L.,Cao, R.,Wang, Y.,Oldfield, E. Farnesyl diphosphate synthase inhibitors with unique ligand-binding geometries. ACS Med Chem Lett, 6:349-354, 2015 Cited by PubMed Abstract: Farnesyl diphosphate synthase (FPPS) is an important drug target for bone resorption, cancer, and some infectious diseases. Here, we report five new structures including two having unique bound ligand geometries. The diamidine inhibitor 7 binds to human FPPS close to the homoallylic (S2) and allosteric (S3) sites and extends into a new site, here called S4. With the bisphosphonate inhibitor 8, two molecules bind to Trypanosoma brucei FPPS, one molecule in the allylic site (S1) and the other close to S2, the first observation of two bisphosphonate molecules bound to FPPS. We also report the structures of apo-FPPS from T. brucei, together with two more bisphosphonate-bound structures (2,9), for purposes of comparison. The diamidine structure is of particular interest because 7 could represent a new lead for lipophilic FPPS inhibitors, while 8 has low micromolar activity against T. brucei, the causative agent of human African trypanosomiasis. PubMed: 25815158DOI: 10.1021/ml500528x 主引用文献が同じPDBエントリー |
| 実験手法 | X-RAY DIFFRACTION (2.21 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






